WINTON GROUP Ltd - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 204 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$421,616
-16.6%
15,475
-31.9%
0.04%
-16.7%
Q2 2023$505,587
-79.1%
22,723
-79.6%
0.04%
-71.4%
Q1 2023$2,416,671
+6.9%
111,573
+0.2%
0.15%
-1.3%
Q4 2022$2,261,376
-15.2%
111,343
+7.0%
0.15%
-14.4%
Q3 2022$2,667,000
-13.3%
104,020
-19.6%
0.17%
+6.7%
Q2 2022$3,076,000
+16.6%
129,344
+10.4%
0.16%
+18.1%
Q1 2022$2,638,000
+12.4%
117,148
-1.2%
0.14%
-2.8%
Q4 2021$2,348,000
-2.5%
118,570
-3.1%
0.14%
+5.2%
Q3 2021$2,407,000
-2.9%
122,324
+8.5%
0.14%
+1.5%
Q2 2021$2,480,000
-1.0%
112,735
+7.0%
0.13%
-7.0%
Q1 2021$2,506,000
-13.3%
105,352
-4.7%
0.14%
-31.6%
Q4 2020$2,891,000
-53.6%
110,509
-69.2%
0.21%
+3.0%
Q3 2020$6,236,000
-32.1%
358,278
-34.4%
0.20%
-14.3%
Q2 2020$9,186,000
+22.1%
546,146
-13.7%
0.24%
+19.1%
Q1 2020$7,524,000
-5.1%
632,799
-3.4%
0.20%
+79.3%
Q4 2019$7,930,000
+835.1%
655,394
+992.5%
0.11%
+1010.0%
Q3 2019$848,000
+209.5%
59,991
+144.1%
0.01%
+100.0%
Q2 2019$274,000
+63.1%
24,579
+95.9%
0.01%
+25.0%
Q4 2018$168,000
-39.4%
12,545
-36.4%
0.00%
-33.3%
Q3 2018$277,000
-22.4%
19,738
-13.0%
0.01%
-33.3%
Q2 2018$357,000
-39.3%
22,694
-36.5%
0.01%
-47.1%
Q1 2018$588,00035,7230.02%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders